Literature DB >> 7436383

Torsion dystonia in Israel.

A D Korczyn, E Kahana, N Zilber, M Streifler, R Carasso, M Alter.   

Abstract

A country-wide search for idiopathic torsion dystonia (ITD) in Israel between 1969 and 1975 revealed 42 patients (41 Jewish and 1 Druze Arab). Prevalence of ITD per million population, age-adjusted to the United States population in 1970, was 10.8 in the total Jewish population (22.0 among Jews of European extraction contrasted with 1.5 among Jews with Afro-Asian forebears). Among Europeans, the highest prevalence was among Jews from Eastern Europe. The average age-adjusted annual incidence rates per million population were 0.43 in the total Jewish population, 0.98 in the Europeans, and 0.11 in the Afro-Asians. Among the 40 patients for whom familial data were available, the majority of cases (26) were sporadic. The other 14 belonged to four unrelated European families, all of Russian-Polish origin. The pattern of inheritance in these four families fits an autosomal dominant model with incomplete penetrance.

Entities:  

Mesh:

Year:  1980        PMID: 7436383     DOI: 10.1002/ana.410080409

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

Review 1.  The genetics of idiopathic torsion dystonia.

Authors:  N A Fletcher
Journal:  J Med Genet       Date:  1990-07       Impact factor: 6.318

Review 2.  The genetics of primary torsion dystonia.

Authors:  U Müller; K G Kupke
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

3.  Inheritance of idiopathic torsion dystonia among Jews.

Authors:  N Zilber; A D Korczyn; E Kahana; K Fried; M Alter
Journal:  J Med Genet       Date:  1984-02       Impact factor: 6.318

4.  A genetic study of idiopathic focal dystonias.

Authors:  M Stojanović; D Cvetković; V S Kostić
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

5.  The prevalence of adult-onset isolated dystonia in Finland 2007-2016.

Authors:  Rebekka Ortiz; Filip Scheperjans; Tuomas Mertsalmi; Eero Pekkonen
Journal:  PLoS One       Date:  2018-11-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.